AKT1 and ovarian cancer: For instance, miR-340 suppressed cancer progression via inactivating signal pathways related to tumorigenesis, such as AKT pathway in gastric cancer [26], Wnt/β-catenin signaling in ovarian cancer [27], and p-PI3K/AKT in human bladder cancer [28].